NICE recommends gene silencing therapy for porphyria patients on NHS

NICE have recommended the use of givosiran, a gene silencing therapy, on the NHS in England, as an option for the treatment of acute haptic porphyria (AHP), a painful disease usually first seen in young women in their 20s.